CFI-400945 in Patients With Advanced/Metastatic Breast Cancer
Status:
Recruiting
Trial end date:
2022-09-30
Target enrollment:
Participant gender:
Summary
The standard or usual treatment for this disease is to undergo chemotherapy to slow the
spread of the disease and relieve some symptoms of cancer. Patients will have already had at
least one chemotherapy treatment for their disease at this stage.
Phase:
Phase 2
Details
Lead Sponsor:
Canadian Cancer Trials Group
Collaborator:
Stand Up To Cancer Canada-Canadian Cancer Society Breast Cancer Dream Team